Electron transfer flavoprotein subunit a, mitochondrial
AltitudeomicsDB
Protein Official symbol |
ETFA |
Aliases |
ETFA |
Chromosomal Location |
15 |
Length |
333 |
Uniprot ID |
P13804 |
EC number |
None |
Protein family Information(Pfam) |
PF01012;PF00766; |
PDB id |
1EFV;1T9G;2A1T;2A1U; |
InterPro ID |
IPR029035;IPR014730;IPR001308;IPR033947;IPR014731;IPR018206;IPR014729; |
dbSNP |
rs119458971 rs119458969 rs1801591 rs119458970 |
AltitudeomicsDB
Protein 1 |
Protein 2 |
Combine Score |
ETFDH |
ETFB |
0.9990000000000001 |
ETFA |
ETFDH |
0.9990000000000001 |
ETFA |
ETFB |
0.9990000000000001 |
ACADM |
ECHS1 |
0.9690000000000001 |
ETFB |
CYCS |
0.9570000000000001 |
ETFA |
ACADM |
0.948 |
ETFA |
CYCS |
0.9440000000000001 |
ETFA |
LYRM5 |
0.919 |
ETFA |
ECHS1 |
0.9109999999999999 |
Association with High Altitude
Protein Official symbol |
Source Organism |
Tissue of Expression |
Level of hypoxia |
Altitude |
Duration of experiment |
Level of expression |
Fold change |
Experiment details |
geographical location |
ethnicity of the patients |
Control group |
Control (Fold change) |
Reference (PMID) |
ETFA |
Human |
Skeletal muscle |
- |
4559 m |
9 day |
downregulated |
-1.2 |
2-DIGE |
Southern Europe |
Italians |
1 |
Fasting control subjects at laboratory in Copenhagen with no caffeine intake |
18937252 |
Association with miRNA
miRTarBase ID |
miRNA |
Species (miRNA) |
Protein Official Symbol |
Human Entrez ID |
Species (Target Gene) |
Experiments |
Support Type |
References (PMID) |
MIRT049145 |
hsa-miR-92a-3p |
Homo sapiens |
ETFA |
2108 |
Homo sapiens |
CLASH |
Functional MTI (Weak) |
23622248 |
MIRT050284 |
hsa-miR-25-3p |
Homo sapiens |
ETFA |
2108 |
Homo sapiens |
CLASH |
Functional MTI (Weak) |
23622248 |
MIRT050733 |
hsa-miR-18a-5p |
Homo sapiens |
ETFA |
2108 |
Homo sapiens |
CLASH |
Functional MTI (Weak) |
23622248 |
MIRT052043 |
hsa-let-7b-5p |
Homo sapiens |
ETFA |
2108 |
Homo sapiens |
CLASH |
Functional MTI (Weak) |
23622248 |
Gene Ontology
ID |
GO ID |
GO Term |
GO Type |
2108 |
GO:0009055 |
electron carrier activity |
GOTERM_MF_DIRECT |
2108 |
GO:0005739 |
mitochondrion |
GOTERM_CC_DIRECT |
2108 |
GO:0070062 |
extracellular exosome |
GOTERM_CC_DIRECT |
2108 |
GO:0022904 |
respiratory electron transport chain |
GOTERM_BP_DIRECT |
2108 |
GO:0003995 |
acid phosphatase activity |
GOTERM_MF_DIRECT |
2108 |
GO:0016491 |
oxidoreductase activity |
GOTERM_MF_DIRECT |
2108 |
GO:0005759 |
mitochondrial matrix |
GOTERM_CC_DIRECT |
2108 |
GO:0055088 |
lipid homeostasis |
GOTERM_BP_DIRECT |
2108 |
GO:0052890 |
lysophosphatidic acid phosphatase activity |
GOTERM_MF_DIRECT |
2108 |
GO:0050660 |
methylarsonate reductase activity |
GOTERM_MF_DIRECT |
2108 |
GO:0000062 |
tRNA binding |
GOTERM_MF_DIRECT |
2108 |
GO:0005515 |
protein binding |
GOTERM_MF_DIRECT |
2108 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase |
GOTERM_BP_DIRECT |
Pathways
Human Entrez ID |
KEGG ID |
KEGG Term |
Association with Disease
Protein Official Symbol |
Human Entrez ID |
Disease Name |
Disease Id |
Disease Semantic Type |
Semantic score |
DSI |
DPI |
Disease Type |
ETFA |
2108 |
Liver carcinoma |
C2239176 |
Neoplastic Process |
0.3 |
0.611 |
0.655 |
disease |
ETFA |
2108 |
Degenerative polyarthritis |
C0029408 |
Disease or Syndrome |
0.3 |
0.611 |
0.655 |
disease |
ETFA |
2108 |
Osteoarthrosis Deformans |
C0086743 |
Disease or Syndrome |
0.3 |
0.611 |
0.655 |
disease |
ETFA |
2108 |
Glutaric Aciduria IIA |
C1856401 |
Disease or Syndrome |
0.5 |
0.611 |
0.655 |
disease |
ETFA |
2108 |
Glutaric Aciduria IIB |
C1856403 |
Disease or Syndrome |
0.5 |
0.611 |
0.655 |
disease |
ETFA |
2108 |
Multiple Acyl Coenzyme A Dehydrogenase Deficiency |
C0268596 |
Disease or Syndrome |
0.64 |
0.611 |
0.655 |
disease |
ETFA |
2108 |
Glutaric Aciduria IIC |
C1856405 |
Disease or Syndrome |
0.5 |
0.611 |
0.655 |
disease |
ETFA |
2108 |
Hyperammonemia |
C0220994 |
Disease or Syndrome |
0.3 |
0.611 |
0.655 |
phenotype |
ETFA |
2108 |
Arthrogryposis |
C0003886 |
Disease or Syndrome |
0.3 |
0.611 |
0.655 |
disease |
ETFA |
2108 |
Intellectual Disability |
C3714756 |
Mental or Behavioral Dysfunction |
0.3 |
0.611 |
0.655 |
group |
ETFA |
2108 |
Rhabdomyolysis |
C0035410 |
Pathologic Function |
0.3 |
0.611 |
0.655 |
phenotype |
ETFA |
2108 |
GLUTARIC ACIDEMIA IIB |
C3278155 |
Disease or Syndrome |
0.3 |
0.611 |
0.655 |
disease |
ETFA |
2108 |
GLUTARIC ACIDEMIA IIA |
C3278154 |
Disease or Syndrome |
0.4 |
0.611 |
0.655 |
disease |
ETFA |
2108 |
GLUTARIC ACIDEMIA IIC |
C3278156 |
Disease or Syndrome |
0.3 |
0.611 |
0.655 |
disease |
Association with Drug
Protein Official Symbol |
Human Entrez ID |
drug_claim_primary_name |
drug_name |
drug_chembl_id |
interaction_types |